Integra Lifesciences Holdings Corp (STU:IL3)
€ 23.8 0.8 (3.48%) Market Cap: 1.83 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 71/100

Integra Lifesciences Holdings Corp at UBS Global Healthcare Conference (Virtual) Transcript

May 20, 2020 / 03:40PM GMT
Release Date Price: €45 (-0.88%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Great. Good morning. My name is Matt Taylor. I'm the UBS U.S. medical supplies devices analyst, and welcome to the next session in our Global Healthcare Virtual Conference. And I'm joined here in the medtech track by management from Integra Lifesciences Holdings. On the line today, we have Carrie Anderson, the Chief Financial Officer; and Michael Beaulieu, who leads the Investor Relations function for Integra.

And today, we'll have a fireside chat session for about 40 minutes, covering a lot of the key topics. As always, if you want to ask a question or steer the conversation, e-mail me or send that through the webcast.

Questions & Answers

Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

So just to get us started, I'll ask one about some of the recent trends. Carrie, leading into the COVID disruption, it looked like your 1Q trends were nicely above

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot